Carmel-based NeurAxis names Craig Blanchard chief commercial officer to lead planned sales, marketing expansion
NeurAxis, Inc. of Carmel announced on Sept. 29, 2026 that Craig Blanchard was appointed chief commercial officer to oversee sales and marketing as the company prepares to expand its commercial organization alongside an anticipated increase in covered lives, the release said.
NeurAxis, Inc., of Carmel, Indiana, on Sept. 29, 2026 appointed Craig Blanchard as its chief commercial officer. The company said Blanchard will oversee commercial functions including sales and marketing as NeurAxis positions for a next phase of commercial growth tied to broader reimbursement coverage and patient access plans.
Blanchard previously served as vice president of product strategy, marketing and field clinical at NICO Corporation, where NeurAxis said he led commercial strategy for minimally invasive neurosurgery technologies that reached more than 40,000 patients and culminated in NICO’s 2024 acquisition by Stryker. The release also notes prior commercial roles at Boston Scientific and Guidant and reiterates NeurAxis’s focus on IB‑Stim, its PENFS device FDA‑cleared for functional abdominal pain and related symptoms in patients ages 8 and older.
Report a correction · Editorial standards · Our source directory
BusinessIndy examines this development and its implications for Indiana businesses and communities using the linked sources.
Related coverage
- Indiana ends routine ambulance diversion for crowded emergency departments
- $120M Federal Investment Targets Rural Indiana Health Capacity, With Consequences for Workforce and Regional Operations
- Federal rural health funding could lower employer coverage costs, expand maternal and telehealth services in Indiana
Reader discussion
Selected stories accept comments during our pilot. Every comment is checked before publication. Community rules and appeals